A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Inhaled GDC-0214, a JAK1 Inhibitor, as Single- and Multiple-Ascending Doses in Healthy Volunteers

被引:0
|
作者
Owen, Ryan [1 ]
Galanter, Joshua [2 ]
Zhu, Rui [2 ]
Cai, Fang [2 ]
Tom, Jennifer [2 ]
Wynne, Chris [3 ]
Durk, Matthew [2 ]
Chen, Liuxi [2 ]
Kenny, Jane [2 ]
She, Gao-hong [2 ]
Vadhavkar, Shweta [2 ]
Hwang, Olivia [2 ]
Chen, Hubert [2 ]
机构
[1] Genentech Inc, San Francisco, CA USA
[2] Genentech Inc, San Francisco, CA 94080 USA
[3] Christchurch Clin Studies Trust, Christchurch, New Zealand
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
052
引用
收藏
页码:AB17 / AB17
页数:1
相关论文
共 50 条
  • [41] A phase I, randomized, ascending-dose study to assess safety, pharmacokinetics, and activity of GDC-8264, a RIP1 inhibitor, in healthy volunteers
    Jones, Nicholas S.
    Kshirsagar, Smita
    Mohanan, Vishnu
    Ramakrishnan, Vidya
    Di Nucci, Flavia
    Ma, Ling
    Mao, Jialin
    Ding, Hao
    Klabunde, Sha
    Vucic, Domagoj
    Pan, Lin
    Lekkerkerker, Annemarie N.
    Chen, Yuan
    Rothenberg, Michael E.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 16 (10): : 1997 - 2009
  • [42] Safety, Tolerability and Pharmacokinetics of Single Doses of Oxytocin Administered via an Inhaled Route in Healthy Females: Randomized, Single-blind, Phase 1 Study
    Fernando, Disala
    Siederer, Sarah
    Singh, Sunita
    Schneider, Ian
    Gupta, Ashutosh
    Powell, Marcy
    Richards, Duncan
    McIntosh, Michelle P.
    Lambert, Peter
    Fowles, Susan
    EBIOMEDICINE, 2017, 22 : 249 - 255
  • [43] A phase 1 study of the safety, tolerability, pharmacodynamics, and pharmacokinetics of tenapanor in healthy Japanese volunteers
    Susanne Johansson
    David P. Rosenbaum
    Mikael Knutsson
    Maria Leonsson-Zachrisson
    Clinical and Experimental Nephrology, 2017, 21 : 407 - 416
  • [44] Phase 1 study to access safety, tolerability, pharmacokinetics, and pharmacodynamics of kynurenine in healthy volunteers
    Al-Karagholi, Mohammad Al-Mandi
    Hansen, Jakob Moller
    Abou-Kassem, Dalia
    Hansted, Anna Koldbro
    Ubhayasekera, Kumari
    Bergquist, Jonas
    Vecsei, Laszlo
    Jansen-Olesen, Inger
    Ashina, Messoud
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2021, 9 (02):
  • [45] A phase 1 study of the safety, tolerability, pharmacodynamics, and pharmacokinetics of tenapanor in healthy Japanese volunteers
    Johansson, Susanne
    Rosenbaum, David P.
    Knutsson, Mikael
    Leonsson-Zachrisson, Maria
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2017, 21 (03) : 407 - 416
  • [46] Phase 1 First-in-Human, Single- and Multiple-Ascending Dose, and Food Effect Studies to Assess the Safety, Tolerability, and Pharmacokinetics of Presatovir for the Treatment of Respiratory Syncytial Virus Infection
    German, Polina
    Xin, Yan
    Chien, Jason W.
    Weng, Winnie
    Mackman, Richard
    Lewis, Sandra A.
    Meng, Amy
    Ling, John
    Mathias, Anita
    JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (08): : 1025 - 1034
  • [47] A Phase 1, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered SRSD107 in Healthy Subjects
    Yue, Patrick
    Qu, Emma
    Pan, Jie
    Weitz, Jeffrey
    Ji, Qunsheng
    BLOOD, 2024, 144 : 4009 - 4010
  • [48] Pharmacokinetics of surotomycin from phase 1 single and multiple ascending dose studies in healthy volunteers
    Chandorkar, Gurudatt
    Zhan, Qiao
    Donovan, Julie
    Rege, Shruta
    Patino, Hernando
    BMC PHARMACOLOGY & TOXICOLOGY, 2017, 18
  • [49] Pharmacokinetics of surotomycin from phase 1 single and multiple ascending dose studies in healthy volunteers
    Gurudatt Chandorkar
    Qiao Zhan
    Julie Donovan
    Shruta Rege
    Hernando Patino
    BMC Pharmacology and Toxicology, 18
  • [50] Orally administered TQ-A3334 to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics single and multiple ascending doses in healthy Chinese subjects
    Hu, Yue
    Zhang, Hong
    Wu, Min
    Huo, Dandan
    Chen, Hong
    Li, Xiaojiao
    Xu, Zhongnan
    Ding, Yanhua
    Niu, Junqi
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E466 - E467